A total of 27.2 million people of all ages were uninsured in 2024, marking a nonsignificant increase from 25.0 million in 2023.

Add-on therapy and substitution monotherapy are both effective second-line treatments for women with idiopathic generalized epilepsy.

Clinical implementation of genetic testing in children with neurodevelopmental disabilities in the Medicaid-enrolled population remains low.

Risk factors for adolescent sleep deprivation, and subsequently increased risk for depression, include early school start times and lifestyle.